Cu-64 labeled trastuzumab

trastuzumab (Cu-64 radiolabeled)

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Cu-64 labeled trastuzumab, covering 2015-12-28 to 2015-12-28. Get the full timeline:

Most recent: Clinical Trial Update: PET Imaging With Cu-64 Labeled Trastuzumab in HER2+ Metastatic Breast Cancer [Phase 1]